Aequus Pharmaceuticals Number Of Shares Shorted vs. Shares Outstanding
| AQS Stock | CAD 0.01 0.00 0.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0205 | 0.0216 |
|
|
For Aequus Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aequus Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aequus Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aequus Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aequus Pharmaceuticals over time as well as its relative position and ranking within its peers.
Aequus |
Aequus Pharmaceuticals Shares Outstanding vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aequus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aequus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Aequus Pharmaceuticals is number one stock in number of shares shorted category among its peers. It also is number one stock in shares outstanding category among its peers creating about 212,214 of Shares Outstanding per Number Of Shares Shorted. Common Stock Shares Outstanding is likely to drop to about 83.9 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aequus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Aequus Shares Outstanding vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Aequus Pharmaceuticals |
| = | 625 |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Aequus Pharmaceuticals |
| = | 132.63 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Aequus Shares Outstanding Comparison
Aequus Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Aequus Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aequus Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aequus Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Aequus Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Aequus Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.4 M | 3 M | |
| Operating Income | -2.8 M | -2.7 M | |
| Net Loss | -3 M | -3.1 M | |
| Income Before Tax | -3 M | -3.1 M | |
| Total Other Income Expense Net | -144.4 K | -151.7 K | |
| Net Loss | -2.1 M | -2.2 M | |
| Net Loss | -3 M | -3.1 M | |
| Income Tax Expense | (3.00) | (2.85) | |
| Net Interest Income | -141 K | -148.1 K | |
| Interest Income | 4.1 K | 3.9 K | |
| Change To Netincome | 432.3 K | 496.8 K | |
| Net Loss | (0.02) | (0.02) | |
| Income Quality | 0.77 | 0.58 | |
| Net Income Per E B T | 0.89 | 0.79 |
Aequus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aequus Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aequus Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aequus Pharmaceuticals' important profitability drivers and their relationship over time.
Use Aequus Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aequus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Aequus Pharmaceuticals Pair Trading
Aequus Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Aequus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aequus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aequus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aequus Pharmaceuticals to buy it.
The correlation of Aequus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aequus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aequus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aequus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aequus Pharmaceuticals position
In addition to having Aequus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.